fda compounding glp-1 crackdown news today issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA crackdown on off-brand Ozempic

Ahmad MS, Krishnan S, Ramakrishna BS, Mathan M, Pulimood AB, Murthy SN

10.1111/jnc.13607 J

doi: 10.7150/ijbs.59965 119 HamalSCherukuriLShaikhKKinningerADoshiJBirudarajuDet al

Wallace GL, Eric Schmitt J, Lenroot R, Viding E, Ordaz S, Rosenthal MA et al (2006)

As obesity is an important risk factor for the development of cardiovascular disease, weight reduction meaningfully contributes to cardiovascular wellness

Joanne Stone, Anu Lala, and Anna Barbieri break down the science behind GLP-1s and weight loss, exploring their impact on heart health, menopause, metabolic disease, inflammation, and overall well-beingwhile also addressing the stigma and cultural pressures women face around weight and aging